Bolt Biotherapeutics Inc (BOLT)

$5.31 +0.35 (7.06%)
Market Cap 10.19M
Revenue (ttm) 7.69M
Net Income (ttm) -63.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -820.81%
Debt to Equity Ratio 0.00
Volume 76,400
Avg Vol 19,428
Day's Range N/A - N/A
Shares Out 1.92M
Stochastic %K 38%
Beta 0.91
Analysts Hold
Price Target $6.00

Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 665 9295
Address:
900 Chesapeake Drive, Redwood City, United States
Vikingsstrade
Vikingsstrade Oct. 3 at 7:34 PM
$DUO $BOLT $AEMD $INAB Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 3 at 2:14 PM
$BOLT Data was originally slated for '1H 2026' now it's 'Q3 2026' so it's really only a quarter delay. Cash burn / qtr was 10M, 50% RIF will significantly reduce cash burn. 38M stockholder equity end of June 30, puts this at about 30M intrinsic value today or approx $15/share. Giving ZERO value to any assets or partnerships w/ big pharma (Genmab / Toray). Tang owns ~9% . I fully expect w/ this great value position, low float (~1.92M shares), and institutional interest that this will either get a TANG BANG buyout offer soon or will have a low-float $GLTO style pump. Either way, rocketships will be launching soon!
0 · Reply
onemillion2012
onemillion2012 Oct. 3 at 5:22 AM
$BCAB very soon.. its time to double up before the stock double.. partnership news very soon now.. Also look at my other looser stocks. $ASMB and the winner of all time shit $BOLT
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 12:42 AM
$NKTR $HUSA $DUO $BOLT "
0 · Reply
MexaTraders
MexaTraders Oct. 2 at 9:16 PM
What's happening on ticker ASTC right now?! Are they pumping ASTC for 300% next? Looks like its breaking out! Shorts overextended - Looks like its about to HALT UP and Squeeze any time! Some will buy it now some will chase it later - dont miss ASTC $MOBX $UFG $ASBP $TRON $BOLT nmx
0 · Reply
prismmarketview
prismmarketview Oct. 2 at 7:28 PM
$BOLT updates Phase 1 study of BDC-4182 with initial data now expected 3Q 2026. Company is reducing workforce by ~50% to extend cash runway into 2027 while advancing Boltbody™ ISAC pipeline. https://prismmarketview.com/companies/bolt-biotherapeutics-inc/
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 2 at 6:40 PM
$BOLT Everyone focused on partnering for BDC-3042, but don't sleep on their ISAC collaborations w/ Genmab and Toray both of which are still priorities according to the PR. "our strategic imperative is the clinical advancement of BDC-4182 and the support of our ISAC collaborations to increase shareholder value". And also don't forget Tang Capital and Vivo are still ~10% owners , Tang is notorious for giving unsolicited buyout offers to companies like $BOLT. IR told me they are open to "BD opportunities that increase shareholder value" Buckle up! FWIW.
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:38 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $NKTR $HUSA $DUO $BOLT
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 2 at 4:15 PM
$BOLT Got an email response from IR relating to partnering 3042. See below email chain. My email: Hi Mr. Quinn, I am a long time investor in BOLT and have been following the progress via PR’s and corporate updates as much as possible, but I had a couple questions that I was hoping you could address, mainly about the partnering process of BDC-3042. Is this process still ongoing w/ confidential and non-confidential discussions? I know that non-binding term sheets were due in June but I haven’t really seen any mention about it since then. Is there anything you can say related to this in terms of progress on partnering? I appreciate any information you can supply. Hope you have a great week. Response (from IR rep, not CEO): Hello, Thank you for reaching out. Regarding your question below, there are no updates on partnering for this program, but we continue to have discussions and remain open to BD opportunities that will drive shareholder value. All the best, SYDNEY BARLOW
1 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 2 at 3:59 PM
$BOLT Could mean no partnership, could mean they are selling the asset 3042, hard to say. All we know is 50% reduction reduces cash burn which is a positive.
0 · Reply
Latest News on BOLT
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Oct 1, 2025, 4:05 PM EDT - 3 days ago

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 14, 2025, 4:05 PM EDT - 7 weeks ago

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 4:05 PM EDT - 5 months ago

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

May 8, 2025, 8:00 AM EDT - 5 months ago

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Apr 30, 2025, 4:05 PM EDT - 5 months ago

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Apr 25, 2025, 1:00 PM EDT - 5 months ago

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 25, 2025, 4:30 PM EDT - 6 months ago

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Mar 24, 2025, 4:20 PM EDT - 6 months ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Feb 25, 2025, 4:05 PM EST - 7 months ago

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Feb 11, 2025, 4:05 PM EST - 8 months ago

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Nov 7, 2024, 10:00 AM EST - 11 months ago

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Sep 6, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Bolt Biotherapeutics Announces Changes to its Board of Directors

Sep 4, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 4, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Sep 2, 2024, 11:11 AM EDT - 1 year ago

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

Sep 2, 2024, 11:00 AM EDT - 1 year ago

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 31, 2024, 11:25 AM EDT - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

Aug 31, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 29, 2024, 8:49 PM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

Aug 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Aug 27, 2024, 11:00 AM EDT - 1 year ago

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

Jul 26, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Jul 25, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Jul 19, 2024, 11:10 AM EDT - 1 year ago

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Jul 3, 2024, 4:47 PM EDT - 1 year ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Jun 24, 2024, 3:36 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

May 17, 2024, 8:37 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

Vikingsstrade
Vikingsstrade Oct. 3 at 7:34 PM
$DUO $BOLT $AEMD $INAB Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 3 at 2:14 PM
$BOLT Data was originally slated for '1H 2026' now it's 'Q3 2026' so it's really only a quarter delay. Cash burn / qtr was 10M, 50% RIF will significantly reduce cash burn. 38M stockholder equity end of June 30, puts this at about 30M intrinsic value today or approx $15/share. Giving ZERO value to any assets or partnerships w/ big pharma (Genmab / Toray). Tang owns ~9% . I fully expect w/ this great value position, low float (~1.92M shares), and institutional interest that this will either get a TANG BANG buyout offer soon or will have a low-float $GLTO style pump. Either way, rocketships will be launching soon!
0 · Reply
onemillion2012
onemillion2012 Oct. 3 at 5:22 AM
$BCAB very soon.. its time to double up before the stock double.. partnership news very soon now.. Also look at my other looser stocks. $ASMB and the winner of all time shit $BOLT
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 12:42 AM
$NKTR $HUSA $DUO $BOLT "
0 · Reply
MexaTraders
MexaTraders Oct. 2 at 9:16 PM
What's happening on ticker ASTC right now?! Are they pumping ASTC for 300% next? Looks like its breaking out! Shorts overextended - Looks like its about to HALT UP and Squeeze any time! Some will buy it now some will chase it later - dont miss ASTC $MOBX $UFG $ASBP $TRON $BOLT nmx
0 · Reply
prismmarketview
prismmarketview Oct. 2 at 7:28 PM
$BOLT updates Phase 1 study of BDC-4182 with initial data now expected 3Q 2026. Company is reducing workforce by ~50% to extend cash runway into 2027 while advancing Boltbody™ ISAC pipeline. https://prismmarketview.com/companies/bolt-biotherapeutics-inc/
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 2 at 6:40 PM
$BOLT Everyone focused on partnering for BDC-3042, but don't sleep on their ISAC collaborations w/ Genmab and Toray both of which are still priorities according to the PR. "our strategic imperative is the clinical advancement of BDC-4182 and the support of our ISAC collaborations to increase shareholder value". And also don't forget Tang Capital and Vivo are still ~10% owners , Tang is notorious for giving unsolicited buyout offers to companies like $BOLT. IR told me they are open to "BD opportunities that increase shareholder value" Buckle up! FWIW.
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:38 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $NKTR $HUSA $DUO $BOLT
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 2 at 4:15 PM
$BOLT Got an email response from IR relating to partnering 3042. See below email chain. My email: Hi Mr. Quinn, I am a long time investor in BOLT and have been following the progress via PR’s and corporate updates as much as possible, but I had a couple questions that I was hoping you could address, mainly about the partnering process of BDC-3042. Is this process still ongoing w/ confidential and non-confidential discussions? I know that non-binding term sheets were due in June but I haven’t really seen any mention about it since then. Is there anything you can say related to this in terms of progress on partnering? I appreciate any information you can supply. Hope you have a great week. Response (from IR rep, not CEO): Hello, Thank you for reaching out. Regarding your question below, there are no updates on partnering for this program, but we continue to have discussions and remain open to BD opportunities that will drive shareholder value. All the best, SYDNEY BARLOW
1 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 2 at 3:59 PM
$BOLT Could mean no partnership, could mean they are selling the asset 3042, hard to say. All we know is 50% reduction reduces cash burn which is a positive.
0 · Reply
rp6577
rp6577 Oct. 2 at 1:39 PM
$BOLT doesn’t necessarily mean no partnership for 3042. It might just not involve sufficient upfront cash to bankroll 4182. The aim of the partnership is really to get the candidate moving forward but with someone else footing the bill
1 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 2 at 1:36 PM
$BOLT Market not liking the RIF news. If it drops below $4 I'm going to avg down.
0 · Reply
Stmkr
Stmkr Oct. 2 at 1:13 PM
$BOLT How is this not down more? No deal so far (none coming). And their only clinical stage asset is toxic from the begininning of the ph1... good luck
1 · Reply
OpenOutcrier
OpenOutcrier Oct. 2 at 12:58 PM
$BOLT (-9.9% pre) Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 https://ooc.bz/l/79175
0 · Reply
Love_To_Learn
Love_To_Learn Oct. 2 at 10:30 AM
$BOLT been shorting you have your low 3's active for over 13 days
0 · Reply
neverhorizontal
neverhorizontal Oct. 2 at 1:05 AM
$BOLT 50% workforce reduction? why? they have enough cash now..
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 2 at 12:46 AM
$BOLT Market doesn't seem to like the news. Perhaps the extending of trial dates.
1 · Reply
DonCorleone77
DonCorleone77 Oct. 1 at 8:16 PM
$BOLT Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study -- As a result of the update to the clinical trial protocol for BDC-4182, Bolt now expects to report initial clinical data in the third quarter of 2026. -- To conserve capital and maintain long-term shareholder value, the company is implementing a workforce reduction of approximately 50%, extending its cash runway into 2027.
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 1 at 4:36 PM
$BOLT Sent an email to CEO get an update on BDC-3042 partnering talks. Last we heard term sheets were due in early June and confidential and non-confidential discussions were ongoing. This was approx. 4 months ago so expecting an update in next month or two. Let's see what he says to me.
1 · Reply
rp6577
rp6577 Oct. 1 at 2:49 PM
$BOLT starting to move. Hold on! $XBI
0 · Reply
rp6577
rp6577 Oct. 1 at 2:38 PM
$BOLT get ready
0 · Reply
BetterDayzz
BetterDayzz Oct. 1 at 1:24 PM
$BOLT Accumulating
0 · Reply